Detalhe da pesquisa
1.
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
Oncologist
; 25(11): 954-962, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812320
2.
Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
Leuk Lymphoma
; 55(10): 2335-40, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24471908